EndoSphere’s inventions provide less invasive, safer and more physiologic treatment for obesity, according to a release from EndoSphere.
The company said obesity is its primary target. EndoSphere develops and commercializes devices such as the SatiSphere duodenal insert.
Read the release on the patient for EndoSphere
Related Articles on Procedures for Obesity:
Top 6 Risk Factors for Weight-Loss Surgery
Allergan Asks FDA to Approve Lap-Band Surgery for Teenagers
Obese Patients at Increased Risk of Surgical Infection After Colectomy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
